AR055096A1 - Inhibidores de 6 -alquiliden -penem beta - lactamasa biciclicos y combinacion de antibioticos de beta - lactama : un antibiotico de amplio espectro - Google Patents
Inhibidores de 6 -alquiliden -penem beta - lactamasa biciclicos y combinacion de antibioticos de beta - lactama : un antibiotico de amplio espectroInfo
- Publication number
- AR055096A1 AR055096A1 ARP060103240A ARP060103240A AR055096A1 AR 055096 A1 AR055096 A1 AR 055096A1 AR P060103240 A ARP060103240 A AR P060103240A AR P060103240 A ARP060103240 A AR P060103240A AR 055096 A1 AR055096 A1 AR 055096A1
- Authority
- AR
- Argentina
- Prior art keywords
- beta
- lactamasa
- alquiliden
- lactama
- penem
- Prior art date
Links
- 239000003242 anti bacterial agent Substances 0.000 title 1
- 229940088710 antibiotic agent Drugs 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 229940126572 wide-spectrum antibiotic Drugs 0.000 title 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 3
- 208000035143 Bacterial infection Diseases 0.000 abstract 3
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 3
- 125000006704 (C5-C6) cycloalkyl group Chemical group 0.000 abstract 2
- HVFLCNVBZFFHBT-ZKDACBOMSA-N cefepime Chemical compound S([C@@H]1[C@@H](C(N1C=1C([O-])=O)=O)NC(=O)\C(=N/OC)C=2N=C(N)SC=2)CC=1C[N+]1(C)CCCC1 HVFLCNVBZFFHBT-ZKDACBOMSA-N 0.000 abstract 2
- 229960002100 cefepime Drugs 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000001072 heteroaryl group Chemical group 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000003782 beta lactam antibiotic agent Substances 0.000 abstract 1
- 125000002619 bicyclic group Chemical group 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000003107 substituted aryl group Chemical group 0.000 abstract 1
- 239000002132 β-lactam antibiotic Substances 0.000 abstract 1
- 229940124586 β-lactam antibiotics Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70280905P | 2005-07-27 | 2005-07-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR055096A1 true AR055096A1 (es) | 2007-08-08 |
Family
ID=37110353
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP060103240A AR055096A1 (es) | 2005-07-27 | 2006-07-27 | Inhibidores de 6 -alquiliden -penem beta - lactamasa biciclicos y combinacion de antibioticos de beta - lactama : un antibiotico de amplio espectro |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20070129344A1 (OSRAM) |
| EP (1) | EP1906954A1 (OSRAM) |
| JP (1) | JP2009502934A (OSRAM) |
| KR (1) | KR20080032637A (OSRAM) |
| CN (1) | CN101232881A (OSRAM) |
| AR (1) | AR055096A1 (OSRAM) |
| AU (1) | AU2006275940A1 (OSRAM) |
| BR (1) | BRPI0613927A2 (OSRAM) |
| CA (1) | CA2615886A1 (OSRAM) |
| CR (1) | CR9691A (OSRAM) |
| EC (1) | ECSP088132A (OSRAM) |
| GT (1) | GT200600331A (OSRAM) |
| IL (1) | IL188843A0 (OSRAM) |
| NO (1) | NO20080314L (OSRAM) |
| PE (1) | PE20070403A1 (OSRAM) |
| RU (1) | RU2008102912A (OSRAM) |
| TW (1) | TW200727897A (OSRAM) |
| WO (1) | WO2007016134A1 (OSRAM) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR039774A1 (es) * | 2002-05-01 | 2005-03-02 | Wyeth Corp | 6-alquiliden-penems biciclicos como inhibidores de beta-lactamasas |
| AR039475A1 (es) * | 2002-05-01 | 2005-02-23 | Wyeth Corp | 6-alquiliden-penems triciclicos como inhibidores de beta-lactamasa |
| TW200716102A (en) * | 2005-06-01 | 2007-05-01 | Wyeth Corp | Bicyclic 6-alkylidene-penems as class-D β -lactamases inhibitors |
| US20090018332A1 (en) * | 2007-06-28 | 2009-01-15 | Wyeth | Processes For Preparing Bicyclic Oxazine Carboxaldehyde and Beta-Lactamase Inhibitors |
| CN103435617B (zh) * | 2013-08-22 | 2016-04-27 | 南京华安药业有限公司 | 一种6,7-二氢-5H-吡咯并[1,2-a]咪唑-2-甲醛的合成方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4206067A (en) * | 1978-10-02 | 1980-06-03 | Chevron Research Company | Thermally stabilized erosion-inhibited functional fluids containing perhalometal compounds and an organic base |
| EP0041768B1 (en) * | 1980-04-24 | 1987-11-11 | Beecham Group Plc | Beta-lactam compounds, their preparation and use |
| US4891369A (en) * | 1986-12-03 | 1990-01-02 | Taiho Pharmaceutical Company, Limited | 2β-Substituted-methylpenicillanic acid derivatives, and salts and esters thereof |
| NZ237202A (en) * | 1990-02-23 | 1994-01-26 | Bristol Myers Squibb Co | Composition containing beta-lactam antibiotic and cationic oligopeptide |
| WO1995028935A1 (en) * | 1994-04-25 | 1995-11-02 | Smithkline Beecham Plc | Pharmaceutical formulations containing a beta-lactamase inhibiting penem in combination with a beta-lactam antibiotic and their use in the treatment of bacterial infections |
| EA200100347A1 (ru) * | 1998-10-15 | 2001-10-22 | Саравак Медичем Фармасьютикалс, Инк. | Метод и композиция для лечения и профилактики туберкулеза |
| GB9928290D0 (en) * | 1999-12-01 | 2000-01-26 | Univ Belfast | Process for preparing ambient temperature ionic liquids |
| AR039774A1 (es) * | 2002-05-01 | 2005-03-02 | Wyeth Corp | 6-alquiliden-penems biciclicos como inhibidores de beta-lactamasas |
| US20040132708A1 (en) * | 2002-05-01 | 2004-07-08 | Wyeth | Process for preparing 6-alkylidene penem derivatives |
| AR039475A1 (es) * | 2002-05-01 | 2005-02-23 | Wyeth Corp | 6-alquiliden-penems triciclicos como inhibidores de beta-lactamasa |
| AR039476A1 (es) * | 2002-05-01 | 2005-02-23 | Wyeth Corp | Proceso para preparar derivados de 6-alquiliden penem |
| AR046041A1 (es) * | 2003-10-03 | 2005-11-23 | Aventis Pharma Inc | Procedimiento para la preparacion de compuestos heterociclicos n-amino sustituidos |
-
2006
- 2006-07-26 AU AU2006275940A patent/AU2006275940A1/en not_active Abandoned
- 2006-07-26 RU RU2008102912/04A patent/RU2008102912A/ru not_active Application Discontinuation
- 2006-07-26 EP EP06800335A patent/EP1906954A1/en not_active Withdrawn
- 2006-07-26 PE PE2006000909A patent/PE20070403A1/es not_active Application Discontinuation
- 2006-07-26 CA CA002615886A patent/CA2615886A1/en not_active Abandoned
- 2006-07-26 GT GT200600331A patent/GT200600331A/es unknown
- 2006-07-26 TW TW095127307A patent/TW200727897A/zh unknown
- 2006-07-26 KR KR1020087004743A patent/KR20080032637A/ko not_active Withdrawn
- 2006-07-26 WO PCT/US2006/028948 patent/WO2007016134A1/en not_active Ceased
- 2006-07-26 JP JP2008524089A patent/JP2009502934A/ja not_active Withdrawn
- 2006-07-26 BR BRPI0613927-2A patent/BRPI0613927A2/pt not_active IP Right Cessation
- 2006-07-26 CN CNA2006800274448A patent/CN101232881A/zh active Pending
- 2006-07-26 US US11/493,178 patent/US20070129344A1/en not_active Abandoned
- 2006-07-27 AR ARP060103240A patent/AR055096A1/es unknown
-
2008
- 2008-01-17 IL IL188843A patent/IL188843A0/en unknown
- 2008-01-18 NO NO20080314A patent/NO20080314L/no not_active Application Discontinuation
- 2008-01-24 EC EC2008008132A patent/ECSP088132A/es unknown
- 2008-01-25 CR CR9691A patent/CR9691A/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| GT200600331A (es) | 2007-02-26 |
| BRPI0613927A2 (pt) | 2011-02-15 |
| CR9691A (es) | 2008-04-02 |
| KR20080032637A (ko) | 2008-04-15 |
| JP2009502934A (ja) | 2009-01-29 |
| TW200727897A (en) | 2007-08-01 |
| CN101232881A (zh) | 2008-07-30 |
| PE20070403A1 (es) | 2007-05-15 |
| ECSP088132A (es) | 2008-03-26 |
| US20070129344A1 (en) | 2007-06-07 |
| NO20080314L (no) | 2008-04-22 |
| IL188843A0 (en) | 2008-08-07 |
| RU2008102912A (ru) | 2009-09-10 |
| WO2007016134A9 (en) | 2009-03-12 |
| EP1906954A1 (en) | 2008-04-09 |
| CA2615886A1 (en) | 2007-02-08 |
| WO2007016134A1 (en) | 2007-02-08 |
| AU2006275940A1 (en) | 2007-02-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TN2017000509A1 (en) | 3-tetrazolyl-benzene-1,2-disulfonamide derivatives as metallo-beta-lactamase inhibitors | |
| EA200501098A1 (ru) | Антибактериальные агенты | |
| BR112014024279A8 (pt) | Compostos heterobicíclicos como inibidores de beta-lactamase, composição farmacêutica, uso de um composto | |
| AR038576A1 (es) | Formulaciones de drogas antibioticas oftalmicas que contienen un compuesto de ciclodextrina y cloruro de cetil piridinio | |
| SG153833A1 (en) | Methods of treatment of endobronchial infections | |
| ATE455786T1 (de) | 6-11 bicyclische ketolidderivate | |
| RU2014109447A (ru) | Азотсодержащие соединения и их применение | |
| BR112012021931A2 (pt) | composto, composição farmacêutica, método para tratar uma infecção bacteriana, e, uso de composto | |
| ATE388153T1 (de) | Quervernetzte glycopeptid-cephalosporin- antibiotika | |
| RU2450015C2 (ru) | Производные аминотиазола и их применение в качестве антибактериальных средств | |
| EA200400086A1 (ru) | Новые производные оксазолидинонов в качестве антибактериальных агентов | |
| ATE450540T1 (de) | Quervernetzte glycopeptid-cephalosporin- antibiotika | |
| PE20200333A1 (es) | Compuestos y metodos para tratar infecciones bacterianas | |
| AR039475A1 (es) | 6-alquiliden-penems triciclicos como inhibidores de beta-lactamasa | |
| ATE556088T1 (de) | Konjugat beinhaltend cephalosporin und glykopeptidantibiotikum | |
| BRPI0607702A2 (pt) | composto, composição farmacêutica, uso do referido composto, e método de preparação de um composto | |
| MX383996B (es) | Antibiótico aminoglucósido novedoso efectivo contra bacterias resistentes a múltiples fármacos. | |
| PE20080283A1 (es) | Profarmacos antimicrobianos de oxazolidinona | |
| PE20190459A1 (es) | Inhibidores de beta-lactamasa | |
| AR066345A1 (es) | Glucopeptidos semisinteticos con actividad antibacteriana | |
| NO20080314L (no) | Bicykliske 6-alkyliden-penem B-laktamase inhibitorer og B-laktam antibiotisk kombinasjon: et bred spektret antibiotika | |
| AR058795A1 (es) | Metodo para inhibir las enzimas beta-lactamasas de clase d en el tratamiento de infeccion bacteriana en un paciente | |
| BRPI0607701A2 (pt) | composto ou um sal, éster, solvato, estereoisÈmero, tautÈmero ou pró-droga farmaceuticamente aceitável do mesmo, composição farmacêutica, uso de uma quantidade antibacterialmente eficaz de um composto junto com um veìculo farmaceuticamente aceitável, e, método de preparação de um composto | |
| AR055097A1 (es) | Inhibidores de 6- alquiliden - penem beta - lactamasa triciclicos y combinacion de antibioticos de beta lactama : un antibiotico de amplio espectro | |
| AR054467A1 (es) | Metodo para inhibir las enzimas beta-lactamasas de clase d en el tratamiento de infeccion bacteriana en un paciente |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |